BioCentury
ARTICLE | Clinical News

CardioGenesis Corp. regulatory update

December 7, 1998 8:00 AM UTC

U.S. Patent No. 5,840,059, covering administration of angiogenic growth factors as part of therapy for severe angina resulting from coronary artery disease, issued to CGCP, Indiana University (Bloomin...